Concentric Analgesics   Report issue

For profit Phase 2
Founded: San Francisco CA United States (2014)

Organization Overview

First Clinical Trial
2017
NCT03307837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Concentric Analgesics

Active Ingredients

Drugs in Phase 2 Trials (2)

ca-008 (6 trials)

vocacapsaicin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bunion (Phase 1)

Congenital Abnormalities (Phase 1)

Hallux Valgus (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 2